Oct. 29 Forum will bring together leaders in healthcare financing and innovation
BOSTON & NEW YORK–(BUSINESS WIRE)–October 28, 2014–
BioPharm Insight – the premier source for breaking news about forward-looking drug developments and forecasting data for the financial services industry — and Remark, producer of premium financial sector conferences around the globe, will host its first healthcare forum focusing on key financing concerns in the life sciences sector, including M&A activity, innovative financing trends and shareholder activism. Top executives from Bank of America/Merrill Lynch (NYSE: BAC), GE Healthcare (GE), UBS (UBS) and Goldman Sachs (GS) will all participate in panels on October 29 in New York.
“This is a tremendous opportunity for life science innovators and thought leaders in financial services,” said Ruth McHenry, managing director of Infinata, BioPharm Insight’s parent company. “We’re delighted to partner with Remark to bring together this impressive roster of speakers and participants for what will no doubt be a day of mutually beneficial, robust dialogue.”
As part of the daylong forum, BioPharm Insight Editor-in-Chief Querida Anderson will moderate a panel on innovative financing trends in healthcare.
“BioPharm Insight is the ideal co-host for our first healthcare forum,” said Erik Wickman, managing director at Remark. “This forum combines Remark’s expertise at hosting thought-provoking, compelling forums – with BioPharm Insight’s keen understanding of the events impacting key drug developments – as well as the deals and financing that will make them possible.”
For registration information and the full forum agenda, visit: http://mergermarketgroup.com/conf/healthcare-merger/.
BioPharm Insight is Infinata’s flagship intelligence solution for the global healthcare markets. With its dedicated team of more than a dozen investigative journalists, BioPharm Insight delivers forward-looking, proprietary intelligence to its subscribers every day. BioPharm Insight’s editorial team covers life sciences from offices in New York and London. For more information about BioPharm Insight, click here.
Infinata, the parent company of BioPharm Insight, and Remark, are both part of the Mergermarket Group.
About Infinata, Inc.
Featuring a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services, Infinata provides personalized technology solutions to turn information into insight. Infinata is a part of the Mergermarket Group. To learn more, visit http://www.infinata.com.
About Remark
Remark organizes more than 70 financial conferences in partnership with the Mergermarket Group’s intelligence services, including Mergermarket and Debtwire. Our custom events are hosted wherever our clients want to develop business. The in-house team leverages an international editorial network to research forward-looking event agendas and recruit prominent industry speakers. We rely on years of experience in event management to execute high-quality meetings across the world.
Infinata
Paulette Song, 781-702-6938
psong@infinata.com
